Changeflow GovPing Pharma & Drug Safety Chemokine receptor modulators and C07D heterocy...
Routine Notice Added Final

Chemokine receptor modulators and C07D heterocyclic compounds patent application

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO published patent application US20260092050A1 for chemokine receptor modulators and C07D heterocyclic compounds. The application discloses novel compounds for modulating chemokine receptor activity with potential therapeutic uses. Inventors include Parcharee Tivitmahaisoon, David J. Wustrow, Mikhail Zibinsky, and Omar Robles. Filing date was January 17, 2025.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO published patent application US20260092050A1 disclosing compounds and methods for modulating chemokine receptor activity. The application covers C07D heterocyclic compounds classified under C07D 403/14 and C07D 401/14, with potential uses in treating conditions involving chemokine receptor dysfunction. Application No. 19030550 was filed January 17, 2025.

Patent applicants and researchers should review the claims to assess freedom-to-operate implications. Legal teams should evaluate the scope of disclosed compounds and methods. No compliance deadlines or regulatory obligations are imposed by this publication.

What to do next

  1. Review patent claims for freedom-to-operate assessment
  2. Evaluate licensing opportunities if developing related compounds
  3. Monitor patent prosecution for claim scope changes

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

Application US20260092050A1 Kind: A1 Apr 02, 2026

Inventors

Parcharee Tivitmahaisoon, David J. Wustrow, Mikhail Zibinsky, Omar Robles

Abstract

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.

CPC Classifications

C07D 403/14 C07D 401/14

Filing Date

2025-01-17

Application No.

19030550

View original document →

Named provisions

Abstract CPC Classifications Inventors Filing Date Application No.

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260092050A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Patent prosecution Intellectual property management
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!